Navigation Links
Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market
Date:5/22/2008

Japanese Distributor to Expand Global Reach of Novel Technology

N. BILLERICA, Mass., May 22 /PRNewswire/ -- Seahorse Bioscience, leaders in real-time measurement of cellular bioenergetics, announced today that Primetech Corporation will become the exclusive supplier of Seahorse XF instruments and consumables in Japan.

"Japan's contribution to research and drug discovery is continuing to grow, as we have seen with the recent acquisition of Millennium by Takeda Pharmaceutical Company and with its increasing pipeline of new drugs in development," Mr. Ryosuke Ogihara, CEO of Primetech Corporation said. "Our customers are interested in studying mitochondrial dysfunction, and in particular its role in cancer, obesity and age-related diseases. Seahorse XF instruments offer the only practical way to study mitochondria in whole cells."

Introduced in June of 2006, Seahorse extracellular flux (XF) analyzers provide the first and only method to non-invasively measure the two major energy producing pathways -- mitochondrial respiration and glycolysis -- in living cells. The microplate-based technology allows scientists to assess the impact of drugs, genetic modifications and environment by monitoring the rate that cells consume oxygen and produce metabolic byproducts including acid and carbon dioxide.

"With a now well-established base of users in North America, we are expanding our reach to academic, biotech and pharma customers throughout the world" said Steve Chomicz, Vice President of Sales and Marketing at Seahorse. "We have chosen to work with Primetech after seeing their commitment to supporting their customers- an important factor in the introduction of innovative research instrumentation."

About Seahorse Bioscience, Inc.

Seahorse Bioscience is changing cancer, obesity, diabetes and age-related drug discovery programs the world over. Seahorse headquarters are located in North Billerica, Massachusetts. For more information, please visit http://www.seahorsebio.com.

About Primetech Corporation

For more than 15 years, Primetech Corporation has been a manufacturer and distributor of high technology medical and analytical science products throughout Japan. Primetech's focus on medical and analytical science products, a technically advanced staff, and an intimate knowledge of the Japanese marketplace allow it to assist companies in penetrating the Japanese market.

If you would like more information about Seahorse Bioscience, Inc., or would like to schedule a meeting with Steve Chomicz, please contact Kristine Hunt at 978-671-1610.


'/>"/>
SOURCE Seahorse Bioscience
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ardea Biosciences Announces Upcoming Corporate Meetings
2. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
3. Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update
4. Pressure BioSciences, Inc. Announces Move to New Corporate Offices
5. Numira Biosciences Names New Board Member
6. DARA BioSciences, Inc. Announces Appointment of Dr. David J. Drutz to Board
7. DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
8. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
9. Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
10. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
11. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... ... conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... 43rd President of the United States of America: George W. Bush , ... the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh ...
(Date:3/23/2017)... ... , ... Sharon Kleyne, host of the nationally syndicated radio program, The Sharon ... talked on her program about how she is looking forward to World Water Day ... important distinction. World Water Day, Kleyne pointed out, is an occasion for looking ahead ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... that help improve all aspects of people’s health and nutrition, announced its product ... products. , Natural Subsistence develops nutritional supplements that help people improve all ...
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics ... serious so build on a solid foundation. As experts in dangerous situations the ... that is coming soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of Quality Assurance and Utilization ... ABQAURP’s dedication to Health Care Quality and Management and Patient Safety. , It is ... the association, but also to the Health Care Quality and Patient Safety movements. Diplomates ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017  Drug diversion is a significant contributing ... overdoses. A new oral fluid monitoring test, announced ... reports more detailed and actionable information to clinicians ... therapy adherence, patient safety, and help to identify ... fluid Rx Evaluation (CORE) system is the first ...
(Date:3/23/2017)...  A new genetic test has been discovered ... who carry HLA-B*15:02 and who are ... deadly side effect of certain medications used to ... HLA-B*15:02 is strongly associated with life-threatening severe ... toxic epidermal necrolysis in patients treated with carbamazepine ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... devices market exhibits a consolidated vendor landscape with the ... the overall market in 2015. These companies are ... Industries, Inc., Hygia Health Services, Inc., and VANGUARD ... global reprocessed medical devices market is witnessing the ...
Breaking Medicine Technology: